Davis Timothy M E
a School of Medicine and Pharmacology, Fremantle Hospital , University of Western Australia , Fremantle , Western Australia , Australia.
Expert Rev Clin Pharmacol. 2016;9(3):341-3. doi: 10.1586/17512433.2016.1108190. Epub 2015 Oct 29.
Pharmacokinetic studies are essential for the development of safe and effective antimalarial treatment regimens, but there are clinical situations in which there are limited data on drug disposition. These include very young children, pregnant women, and where drug interactions may alter treatment response. New approaches such as sampling methods involving low volumes and minimal preparation such as dried blood spots, highly sensitive and specific multidrug assays, and population PK analyses which can evaluate the influence of covariates such as age, pregnancy and coadministered therapies, can generate robust data that inform treatment in the most challenging situations in the tropics.
